Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services tags : Covid save search
Financial Management Corporation Selects Harte Hanks to Provide Employees with At-Home Covid Tests
Published: 2022-03-22 (Crawled : 18:00) - hartehanks.com
HHS 4 | $7.01 -1.73% 9.9K
|
Professional, Scientific, and T...
|
| O: -0.54%
H: 2.99%
C: 2.45%
covid corporation test
mRNA Manufacturing and Synthesis Services Market worth $22.6 Billion by 2031- Growing Beyond COVID-19 Application
Published: 2022-02-10 (Crawled : 12:00) - prnewswire.com
LZAGF | $558.779 -19.1% 23
|
Health Technology
|
| O: -1.72%
H: 0.46%
C: -0.51%
LZAGY | $57.57 0.02% 93K
|
Professional, Scientific, and T...
|
| O: -1.31%
H: 2.63%
C: 0.75%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
IONS | $42.455 1.47% 1.45% 730K
|
Health Technology
|
| O: 0.7%
H: 3.82%
C: 0.78%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -2.42%
H: 0.49%
C: -2.63%
covid-19 application covid services growing
Global COVID-19 EIA/ELISA Medical Devices Market Landscape Report 2021: Comparative Analysis of the Products at Various Stages of Development
Published: 2022-01-18 (Crawled : 14:00) - prnewswire.com
OCDX | News | $17.63 0.45%
|
|
| O: -2.65%
H: 1.39%
C: -0.91%
IPA | $1.22 -0.81% 23K
|
Professional, Scientific, and T...
|
| O: 0.32%
H: 2.22%
C: -1.59%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -2.15%
H: 0.0%
C: 0.0%
TECH | $63.48 -0.33% -0.33% 980K
|
Health Technology
|
| O: -4.04%
H: 0.39%
C: -1.01%
ADMA 4 | $6.465 -1.15% -1.16% 1.7M
|
Health Technology
|
| O: 7.34%
H: 0.0%
C: 0.0%
covid-19 ces device covid report
Molecular Partners Finalizes License Agreement with Novartis for Ensovibep for COVID-19
Published: 2022-01-18 (Crawled : 07:00) - globenewswire.com
MOLN | $3.88 -3.54% 200
|
Professional, Scientific, and T...
|
| O: -8.83%
H: 0.4%
C: -4.19%
covid-19 novartis ensovibep license covid molecular
iSpecimen Expands Support of COVID-19 Research with Availability of Sequenced Specimens to Detect Variants
Published: 2022-01-13 (Crawled : 14:00) - biospace.com/
ISPC | $0.2772 -6.07% -6.46% 280K
|
Professional, Scientific, and T...
|
| O: 7.99%
H: 0.78%
C: -9.74%
covid-19 research covid
Molecular Partners Presents Results from a Phase 2a Trial of Ensovibep in 12 COVID-19 Patients at ESWI 2021
Published: 2021-12-06 (Crawled : 07:00) - globenewswire.com
MOLN | $3.88 -3.54% 200
|
Professional, Scientific, and T...
|
| O: -1.84%
H: 0.0%
C: 0.0%
phase 2 ensovibep trial covid results molecular phase 2b
iSpecimen Selected by U.S. Government and Private Researchers to Supply Critical Human Biospecimens for Advanced Phase of COVID-19 Research
Published: 2021-11-22 (Crawled : 14:30) - biospace.com/
ISPC | $0.2772 -6.07% -6.46% 280K
|
Professional, Scientific, and T...
|
| O: 131.5%
H: 12.12%
C: -22.04%
covid research
Worldwide Antimicrobial Coatings Industry to 2026 - Growing Usage of Antimicrobial Coatings in Novel Applications Such as COVID-19 Presents Opportunities
Published: 2021-09-03 (Crawled : 20:00) - prnewswire.com
LZAGY | $57.57 0.02% 93K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
LZAGF | $558.779 -19.1% 23
|
Health Technology
| Email alert
Add to watchlist
covid growing application
TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit
Published: 2021-07-21 (Crawled : 12:00) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: 2.73%
H: 0.0%
C: -9.54%
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.55%
H: 1.65%
C: 1.1%
covid disease media infectious disease therapy t-cell
ImmunoPrecise Announces Data from Preclinical Study of TATX-03 PolyTope™ Monoclonal Antibody Cocktail Candidate Against COVID-19
Published: 2021-02-19 (Crawled : 16:00) - biospace.com/
IPA | $1.22 -0.81% 23K
|
Professional, Scientific, and T...
|
| O: 16.87%
H: 5.09%
C: -11.12%
covid antibody preclinical pre-clinical
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.